ESCRS - Mayo Clinic researchers demonstrate value of second opinions ;

ESCRS - Mayo Clinic researchers demonstrate value of second opinions ;

Mayo Clinic researchers demonstrate value of second opinions

88 percent of patients go home with a new or refined diagnosis

Mayo Clinic researchers demonstrate value of second opinions

Colin Kerr

Published: Tuesday, April 4, 2017

Second Opinion?

In a new study, the Mayo Clinic has reported that many patients come to their clinic for a second opinion or diagnosis confirmation before treatment for a complex condition. As many as 88 percent of those patients go home with a new or refined diagnosis. Conversely, only 12 percent receive confirmation that the original diagnosis was complete and correct. These findings were published online in the Journal of Evaluation in Clinical Practice. The research team was led by James Naessens, Sc.D., a health care policy researcher at Mayo Clinic.

Tags: patients

Latest Articles

Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

ESCRS Heritage Programme

Visionaries past and present.

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

;